
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 23, 2024, titled "WHO prequalifies Zydus s Typhoid Vi Conjugate Vaccine, ZyVac? TCV".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 23, 2024, titled "WHO prequalifies Zydus s Typhoid Vi Conjugate Vaccine, ZyVac? TCV".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences